메뉴 건너뛰기




Volumn 36, Issue , 2014, Pages 140-146

Phenotypes associated with inherited and developmental somatic mutations in genes encoding mTOR pathway components

Author keywords

Everolimus; MTOR; MTORC1; MTORC2; Rapamycin; Sirolimus

Indexed keywords

DISHEVELED EGL 10 AND PLECKSTRIN DOMAIN CONTAINING PROTEIN 5; EVEROLIMUS; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN COMPLEX 1; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROTEIN; PROTEIN AKT3; PROTEIN KINASE B; PROTEIN KINASE LKB1; RAPAMYCIN; TBC1 DOMAIN FAMILY MEMBER 7; TUBERIN; TUBEROUS SCLEROSIS COMPLEX 1; UNCLASSIFIED DRUG;

EID: 84912125429     PISSN: 10849521     EISSN: 10963634     Source Type: Journal    
DOI: 10.1016/j.semcdb.2014.09.018     Document Type: Review
Times cited : (8)

References (66)
  • 1
    • 84894486696 scopus 로고    scopus 로고
    • Nutrient regulation of the mTOR complex 1 signalling pathway
    • Kim S.G., Buel G.R., Blenis J. Nutrient regulation of the mTOR complex 1 signalling pathway. Mol Cells 2013, 35(6):463-473.
    • (2013) Mol Cells , vol.35 , Issue.6 , pp. 463-473
    • Kim, S.G.1    Buel, G.R.2    Blenis, J.3
  • 2
    • 44449161481 scopus 로고    scopus 로고
    • The TSC1-TSC2 complex: a molecular switchboard controlling cell growth
    • Huang J., Manning B.D. The TSC1-TSC2 complex: a molecular switchboard controlling cell growth. Biochem J 2008, 412(2):179-190.
    • (2008) Biochem J , vol.412 , Issue.2 , pp. 179-190
    • Huang, J.1    Manning, B.D.2
  • 3
    • 49149088555 scopus 로고    scopus 로고
    • Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis
    • Ehninger D., Han S., Shilyansky C., Zhou Y., Li W., Kwiatkowski D.J., et al. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis. Nat Med 2008, 14(8):843-848.
    • (2008) Nat Med , vol.14 , Issue.8 , pp. 843-848
    • Ehninger, D.1    Han, S.2    Shilyansky, C.3    Zhou, Y.4    Li, W.5    Kwiatkowski, D.J.6
  • 5
    • 84877965001 scopus 로고    scopus 로고
    • Regulation of mTORC1 and its impact on gene expression at a glance
    • Laplante M., Sabatini D.M. Regulation of mTORC1 and its impact on gene expression at a glance. J Cell Sci 2013, 126(Pt 8):1713-1719.
    • (2013) J Cell Sci , vol.126 , pp. 1713-1719
    • Laplante, M.1    Sabatini, D.M.2
  • 6
    • 79955779584 scopus 로고    scopus 로고
    • MTOR links oncogenic signaling to tumor cell metabolism
    • Yecies J.L., Manning B.D. mTOR links oncogenic signaling to tumor cell metabolism. J Mol Med (Berl) 2011, 89(3):221-228.
    • (2011) J Mol Med (Berl) , vol.89 , Issue.3 , pp. 221-228
    • Yecies, J.L.1    Manning, B.D.2
  • 7
    • 84894628256 scopus 로고    scopus 로고
    • Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging
    • Parkhitko A.A., et al. Kinase mTOR: regulation and role in maintenance of cellular homeostasis, tumor development, and aging. Biochemistry (Mosc) 2014, 79(2):88-101.
    • (2014) Biochemistry (Mosc) , vol.79 , Issue.2 , pp. 88-101
    • Parkhitko, A.A.1
  • 8
    • 82555166000 scopus 로고    scopus 로고
    • MTOR signaling in disease
    • Dazert E., Hall M.N. mTOR signaling in disease. Curr Opin Cell Biol 2011, 23(6):744-755.
    • (2011) Curr Opin Cell Biol , vol.23 , Issue.6 , pp. 744-755
    • Dazert, E.1    Hall, M.N.2
  • 9
    • 77949882117 scopus 로고    scopus 로고
    • The tuberous sclerosis complex
    • Orlova K.A., Crino P.B. The tuberous sclerosis complex. Ann N Y Acad Sci 2010, 1184:87-105.
    • (2010) Ann N Y Acad Sci , vol.1184 , pp. 87-105
    • Orlova, K.A.1    Crino, P.B.2
  • 13
    • 84896320213 scopus 로고    scopus 로고
    • Fetal brain mTOR signaling activation in tuberous sclerosis complex
    • Tsai V., Parker W.E., Orlova K.A., Baybis M., Chi A.W., Berg B.D., et al. Fetal brain mTOR signaling activation in tuberous sclerosis complex. Cereb Cortex 2014, 24(2):315-327.
    • (2014) Cereb Cortex , vol.24 , Issue.2 , pp. 315-327
    • Tsai, V.1    Parker, W.E.2    Orlova, K.A.3    Baybis, M.4    Chi, A.W.5    Berg, B.D.6
  • 14
    • 84872088946 scopus 로고    scopus 로고
    • Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial
    • Franz D.N., Belousova E., Sparagana S., Bebin E.M., Frost M., Kuperman R., et al. Efficacy and safety of everolimus for subependymal giant cell astrocytomas associated with tuberous sclerosis complex (EXIST-1): a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 2013, 381(9861):125-132.
    • (2013) Lancet , vol.381 , Issue.9861 , pp. 125-132
    • Franz, D.N.1    Belousova, E.2    Sparagana, S.3    Bebin, E.M.4    Frost, M.5    Kuperman, R.6
  • 15
    • 84874746597 scopus 로고    scopus 로고
    • Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
    • Bissler J.J., Kingswood J.C., Radzikowska E., Zonnenberg B.A., Frost M., Belousova E., et al. Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial. Lancet 2013, 381(9869):817-824.
    • (2013) Lancet , vol.381 , Issue.9869 , pp. 817-824
    • Bissler, J.J.1    Kingswood, J.C.2    Radzikowska, E.3    Zonnenberg, B.A.4    Frost, M.5    Belousova, E.6
  • 17
    • 84884511014 scopus 로고    scopus 로고
    • Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference
    • G. International Tuberous Sclerosis Complex Consensus
    • Krueger D.A., Northrup H. Tuberous sclerosis complex surveillance and management: recommendations of the 2012 international tuberous sclerosis complex consensus conference. Pediatr Neurol 2013, 49(4):255-265. G. International Tuberous Sclerosis Complex Consensus.
    • (2013) Pediatr Neurol , vol.49 , Issue.4 , pp. 255-265
    • Krueger, D.A.1    Northrup, H.2
  • 18
    • 84927171958 scopus 로고    scopus 로고
    • Renal tumours in a Tsc2 mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin
    • Online publication on 17 March 2014.
    • Yang J., Kalogerou M., Samsel P.A., Zhang Y., Griffiths D.F., Gallacher J., et al. Renal tumours in a Tsc2 mouse model do not show feedback inhibition of Akt and are effectively prevented by rapamycin. Oncogene 2014, Online publication on 17 March 2014; doi: 10.1038/onc.2014.17.
    • (2014) Oncogene
    • Yang, J.1    Kalogerou, M.2    Samsel, P.A.3    Zhang, Y.4    Griffiths, D.F.5    Gallacher, J.6
  • 19
    • 42949140259 scopus 로고    scopus 로고
    • Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex
    • Zeng L.H., Xu L., Gutmann D.H., Wong M. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex. Ann Neurol 2008, 63(4):444-453.
    • (2008) Ann Neurol , vol.63 , Issue.4 , pp. 444-453
    • Zeng, L.H.1    Xu, L.2    Gutmann, D.H.3    Wong, M.4
  • 21
    • 78049510428 scopus 로고    scopus 로고
    • Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis
    • Krueger D.A., Care M.M., Holland K., Agricola K., Tudor C., Mangeshkar P., et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med 2010, 363(19):1801-1811.
    • (2010) N Engl J Med , vol.363 , Issue.19 , pp. 1801-1811
    • Krueger, D.A.1    Care, M.M.2    Holland, K.3    Agricola, K.4    Tudor, C.5    Mangeshkar, P.6
  • 24
    • 84865371057 scopus 로고    scopus 로고
    • TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1
    • Dibble C.C., Elis W., Menon S., Qin W., Klekota J., Asara J.M., et al. TBC1D7 is a third subunit of the TSC1-TSC2 complex upstream of mTORC1. Mol Cell 2012, 47(4):535-546.
    • (2012) Mol Cell , vol.47 , Issue.4 , pp. 535-546
    • Dibble, C.C.1    Elis, W.2    Menon, S.3    Qin, W.4    Klekota, J.5    Asara, J.M.6
  • 25
    • 84890134229 scopus 로고    scopus 로고
    • Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly
    • Capo-Chichi J.M., Tcherkezian J., Hamdan F.F., Decarie J.C., Dobrzeniecka S., Patry L., et al. Disruption of TBC1D7, a subunit of the TSC1-TSC2 protein complex, in intellectual disability and megalencephaly. J Med Genet 2013, 50(11):740-744.
    • (2013) J Med Genet , vol.50 , Issue.11 , pp. 740-744
    • Capo-Chichi, J.M.1    Tcherkezian, J.2    Hamdan, F.F.3    Decarie, J.C.4    Dobrzeniecka, S.5    Patry, L.6
  • 26
    • 84896109407 scopus 로고    scopus 로고
    • TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease
    • Alfaiz A.A., Micale L., Mandriani B., Augello B., Pellico M.T., Chrast J., et al. TBC1D7 mutations are associated with intellectual disability, macrocrania, patellar dislocation, and celiac disease. Hum Mutat 2014, 35(4):447-451.
    • (2014) Hum Mutat , vol.35 , Issue.4 , pp. 447-451
    • Alfaiz, A.A.1    Micale, L.2    Mandriani, B.3    Augello, B.4    Pellico, M.T.5    Chrast, J.6
  • 27
    • 84873349273 scopus 로고    scopus 로고
    • Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis
    • Sarnat H., Flores-Sarnat L., Crino P., Hader W., Bello-Espinosa L. Hemimegalencephaly: foetal tauopathy with mTOR hyperactivation and neuronal lipidosis. Folia Neuropathol 2012, 50(4):330-345.
    • (2012) Folia Neuropathol , vol.50 , Issue.4 , pp. 330-345
    • Sarnat, H.1    Flores-Sarnat, L.2    Crino, P.3    Hader, W.4    Bello-Espinosa, L.5
  • 28
    • 0029884689 scopus 로고    scopus 로고
    • Synaptogenesis in hemimegalencephaly: the numerical density of asymmetric and symmetric synapses in the cerebral cortex
    • O'Kusky J.R., Akers M.A., Vinters H.V. Synaptogenesis in hemimegalencephaly: the numerical density of asymmetric and symmetric synapses in the cerebral cortex. Acta Neuropathol 1996, 92(2):156-163.
    • (1996) Acta Neuropathol , vol.92 , Issue.2 , pp. 156-163
    • O'Kusky, J.R.1    Akers, M.A.2    Vinters, H.V.3
  • 29
    • 0036563399 scopus 로고    scopus 로고
    • Hemimegalencephaly: part 1. Genetic, clinical, and imaging aspects
    • [discussion 384]
    • Flores-Sarnat L. Hemimegalencephaly: part 1. Genetic, clinical, and imaging aspects. J Child Neurol 2002, 17(5):373-384. [discussion 384].
    • (2002) J Child Neurol , vol.17 , Issue.5 , pp. 373-384
    • Flores-Sarnat, L.1
  • 30
    • 84864402732 scopus 로고    scopus 로고
    • De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly
    • Lee J.H., Huynh M., Silhavy J.L., Kim S., Dixon-Salazar T., Heiberg A., et al. De novo somatic mutations in components of the PI3K-AKT3-mTOR pathway cause hemimegalencephaly. Nat Genet 2012, 44(8):941-945.
    • (2012) Nat Genet , vol.44 , Issue.8 , pp. 941-945
    • Lee, J.H.1    Huynh, M.2    Silhavy, J.L.3    Kim, S.4    Dixon-Salazar, T.5    Heiberg, A.6
  • 31
    • 84855958205 scopus 로고    scopus 로고
    • MTOR: a pathogenic signaling pathway in developmental brain malformations
    • Crino P.B. mTOR: a pathogenic signaling pathway in developmental brain malformations. Trends Mol Med 2011, 17(12):734-742.
    • (2011) Trends Mol Med , vol.17 , Issue.12 , pp. 734-742
    • Crino, P.B.1
  • 33
    • 34447637612 scopus 로고    scopus 로고
    • Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a homozygous 7-kilobase deletion in LYK5
    • Puffenberger E.G., Strauss K.A., Ramsey K.E., Craig D.W., Stephan D.A., Robinson D.L., et al. Polyhydramnios, megalencephaly and symptomatic epilepsy caused by a homozygous 7-kilobase deletion in LYK5. Brain 2007, 130(Pt 7):1929-1941.
    • (2007) Brain , vol.130 , pp. 1929-1941
    • Puffenberger, E.G.1    Strauss, K.A.2    Ramsey, K.E.3    Craig, D.W.4    Stephan, D.A.5    Robinson, D.L.6
  • 34
    • 77951783390 scopus 로고    scopus 로고
    • STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice
    • Orlova K.A., Parker W.E., Heuer G.G., Tsai V., Yoon J., Baybis M., et al. STRADalpha deficiency results in aberrant mTORC1 signaling during corticogenesis in humans and mice. J Clin Invest 2010, 120(5):1591-1602.
    • (2010) J Clin Invest , vol.120 , Issue.5 , pp. 1591-1602
    • Orlova, K.A.1    Parker, W.E.2    Heuer, G.G.3    Tsai, V.4    Yoon, J.5    Baybis, M.6
  • 36
    • 84897110754 scopus 로고    scopus 로고
    • Epilepsy genetics revolutionizes clinical practice
    • Scheffer I.E. Epilepsy genetics revolutionizes clinical practice. Neuropediatrics 2014, 45(2):70-74.
    • (2014) Neuropediatrics , vol.45 , Issue.2 , pp. 70-74
    • Scheffer, I.E.1
  • 38
    • 84902167691 scopus 로고    scopus 로고
    • DEPDC5 does it all: shared genetics for diverse epilepsy syndromes
    • Poduri A. DEPDC5 does it all: shared genetics for diverse epilepsy syndromes. Ann Neurol 2014, 75(5):631-633.
    • (2014) Ann Neurol , vol.75 , Issue.5 , pp. 631-633
    • Poduri, A.1
  • 39
    • 84902281810 scopus 로고    scopus 로고
    • Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations
    • Scheffer I.E., Heron S.E., Regan B.M., Mandelstam S., Crompton D.E., Hodgson B.L., et al. Mutations in mammalian target of rapamycin regulator DEPDC5 cause focal epilepsy with brain malformations. Ann Neurol 2014, 75(5):782-787.
    • (2014) Ann Neurol , vol.75 , Issue.5 , pp. 782-787
    • Scheffer, I.E.1    Heron, S.E.2    Regan, B.M.3    Mandelstam, S.4    Crompton, D.E.5    Hodgson, B.L.6
  • 40
    • 84878357685 scopus 로고    scopus 로고
    • A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1
    • Bar-Peled L., Chantranupong L., Cherniack A.D., Chen W.W., Ottina K.A., Grabiner B.C., et al. A tumor suppressor complex with GAP activity for the Rag GTPases that signal amino acid sufficiency to mTORC1. Science 2013, 340(6136):1100-1106.
    • (2013) Science , vol.340 , Issue.6136 , pp. 1100-1106
    • Bar-Peled, L.1    Chantranupong, L.2    Cherniack, A.D.3    Chen, W.W.4    Ottina, K.A.5    Grabiner, B.C.6
  • 41
    • 54549099013 scopus 로고    scopus 로고
    • PTEN hamartoma tumor syndromes
    • Blumenthal G.M., Dennis P.A. PTEN hamartoma tumor syndromes. Eur J Hum Genet 2008, 16(11):1289-1300.
    • (2008) Eur J Hum Genet , vol.16 , Issue.11 , pp. 1289-1300
    • Blumenthal, G.M.1    Dennis, P.A.2
  • 43
    • 85029461725 scopus 로고    scopus 로고
    • Lhermitte-Duclos disease in orphanet
    • Lhermitte-Duclos disease, in orphanet, 2006.
    • (2006)
  • 44
    • 52049126174 scopus 로고    scopus 로고
    • Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin
    • Squarize C.H., Castilho R.M., Gutkind J.S. Chemoprevention and treatment of experimental Cowden's disease by mTOR inhibition with rapamycin. Cancer Res 2008, 68(17):7066-7072.
    • (2008) Cancer Res , vol.68 , Issue.17 , pp. 7066-7072
    • Squarize, C.H.1    Castilho, R.M.2    Gutkind, J.S.3
  • 45
    • 79958813923 scopus 로고    scopus 로고
    • Rapamycin treatment suppresses epileptogenic activity in conditional Pten knockout mice
    • D'Arcangelo G. Rapamycin treatment suppresses epileptogenic activity in conditional Pten knockout mice. Cell Cycle 2010, 9(13):2487-2488.
    • (2010) Cell Cycle , vol.9 , Issue.13 , pp. 2487-2488
    • D'Arcangelo, G.1
  • 47
    • 84860389181 scopus 로고    scopus 로고
    • A mosaic activating mutation in AKT1 associated with the Proteus syndrome
    • Lindhurst M.J., Sapp J.C., Teer J.K., Johnston J.J., Finn E.M., Peters K., et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N Engl J Med 2011, 365(7):611-619.
    • (2011) N Engl J Med , vol.365 , Issue.7 , pp. 611-619
    • Lindhurst, M.J.1    Sapp, J.C.2    Teer, J.K.3    Johnston, J.J.4    Finn, E.M.5    Peters, K.6
  • 49
    • 0035928416 scopus 로고    scopus 로고
    • Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes
    • Zhou X., Hampel H., Thiele H., Gorlin R.J., Hennekam R.C., Parisi M., et al. Association of germline mutation in the PTEN tumour suppressor gene and Proteus and Proteus-like syndromes. Lancet 2001, 358(9277):210-211.
    • (2001) Lancet , vol.358 , Issue.9277 , pp. 210-211
    • Zhou, X.1    Hampel, H.2    Thiele, H.3    Gorlin, R.J.4    Hennekam, R.C.5    Parisi, M.6
  • 51
  • 53
    • 84884469901 scopus 로고    scopus 로고
    • Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review)
    • Banno K., Kisu I., Yanokura M., Masuda K., Ueki A., Kobayashi Y., et al. Hereditary gynecological tumors associated with Peutz-Jeghers syndrome (Review). Oncol Lett 2013, 6(5):1184-1188.
    • (2013) Oncol Lett , vol.6 , Issue.5 , pp. 1184-1188
    • Banno, K.1    Kisu, I.2    Yanokura, M.3    Masuda, K.4    Ueki, A.5    Kobayashi, Y.6
  • 54
    • 77953985258 scopus 로고    scopus 로고
    • Peutz-Jeghers syndrome: a systematic review and recommendations for management
    • Beggs A.D., Latchford A.R., Vasen H.F., Moslein G., Alonso A., Aretz S., et al. Peutz-Jeghers syndrome: a systematic review and recommendations for management. Gut 2010, 59(7):975-986.
    • (2010) Gut , vol.59 , Issue.7 , pp. 975-986
    • Beggs, A.D.1    Latchford, A.R.2    Vasen, H.F.3    Moslein, G.4    Alonso, A.5    Aretz, S.6
  • 56
    • 12144287284 scopus 로고    scopus 로고
    • LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1
    • Lizcano J.M., Goransson O., Toth R., Deak M., Morrice N.A., Boudeau J., et al. LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1. EMBO J 2004, 23(4):833-843.
    • (2004) EMBO J , vol.23 , Issue.4 , pp. 833-843
    • Lizcano, J.M.1    Goransson, O.2    Toth, R.3    Deak, M.4    Morrice, N.A.5    Boudeau, J.6
  • 57
    • 84907994949 scopus 로고    scopus 로고
    • AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease
    • Grahame Hardie D. AMP-activated protein kinase: a key regulator of energy balance with many roles in human disease. J Intern Med 2014, DOI: 10.1111/joim.12268.
    • (2014) J Intern Med
    • Grahame Hardie, D.1
  • 58
    • 84865955793 scopus 로고    scopus 로고
    • Target of rapamycin (TOR)-based therapy for cardiomyopathy: evidence from zebrafish and human studies
    • Kushwaha S., Xu X. Target of rapamycin (TOR)-based therapy for cardiomyopathy: evidence from zebrafish and human studies. Trends Cardiovasc Med 2012, 22(2):39-43.
    • (2012) Trends Cardiovasc Med , vol.22 , Issue.2 , pp. 39-43
    • Kushwaha, S.1    Xu, X.2
  • 60
    • 84856219440 scopus 로고    scopus 로고
    • Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis
    • Mirzaa G.M., Conway R.L., Gripp K.W., Lerman-Sagie T., Siegel D.H., deVries L.S., et al. Megalencephaly-capillary malformation (MCAP) and megalencephaly-polydactyly-polymicrogyria-hydrocephalus (MPPH) syndromes: two closely related disorders of brain overgrowth and abnormal brain and body morphogenesis. Am J Med Genet A 2012, 158A(2):269-291.
    • (2012) Am J Med Genet A , vol.158 A , Issue.2 , pp. 269-291
    • Mirzaa, G.M.1    Conway, R.L.2    Gripp, K.W.3    Lerman-Sagie, T.4    Siegel, D.H.5    deVries, L.S.6
  • 61
    • 84876806696 scopus 로고    scopus 로고
    • Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP
    • Mirzaa G.M., Riviere J.B., Dobyns W.B. Megalencephaly syndromes and activating mutations in the PI3K-AKT pathway: MPPH and MCAP. Am J Med Genet C Semin Med Genet 2013, 163C(2):122-130.
    • (2013) Am J Med Genet C Semin Med Genet , vol.163 C , Issue.2 , pp. 122-130
    • Mirzaa, G.M.1    Riviere, J.B.2    Dobyns, W.B.3
  • 62
    • 84899650142 scopus 로고    scopus 로고
    • De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome
    • Mirzaa G.M., Parry D.A., Fry A.E., Giamanco K.A., Schwartzentruber J., Vanstone M., et al. De novo CCND2 mutations leading to stabilization of cyclin D2 cause megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome. Nat Genet 2014, 46(5):510-515.
    • (2014) Nat Genet , vol.46 , Issue.5 , pp. 510-515
    • Mirzaa, G.M.1    Parry, D.A.2    Fry, A.E.3    Giamanco, K.A.4    Schwartzentruber, J.5    Vanstone, M.6
  • 63
    • 37549016789 scopus 로고    scopus 로고
    • Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation
    • Wong M. Mechanisms of epileptogenesis in tuberous sclerosis complex and related malformations of cortical development with abnormal glioneuronal proliferation. Epilepsia 2008, 49(1):8-21.
    • (2008) Epilepsia , vol.49 , Issue.1 , pp. 8-21
    • Wong, M.1
  • 64
    • 84875716234 scopus 로고    scopus 로고
    • Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin
    • Yang J., Kalogerou M., Gallacher J., Sampson J.R., Shen M.H. Renal tumours in a Tsc1+/- mouse model show epigenetic suppression of organic cation transporters Slc22a1, Slc22a2 and Slc22a3, and do not respond to metformin. Eur J Cancer 2013, 49(6):1479-1490.
    • (2013) Eur J Cancer , vol.49 , Issue.6 , pp. 1479-1490
    • Yang, J.1    Kalogerou, M.2    Gallacher, J.3    Sampson, J.R.4    Shen, M.H.5
  • 65
    • 84857416727 scopus 로고    scopus 로고
    • Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC)
    • Auricchio N., Malinowska I., Shaw R., Manning B.D., Kwiatkowski D.J. Therapeutic trial of metformin and bortezomib in a mouse model of tuberous sclerosis complex (TSC). PLoS ONE 2012, 7(2):e31900.
    • (2012) PLoS ONE , vol.7 , Issue.2 , pp. e31900
    • Auricchio, N.1    Malinowska, I.2    Shaw, R.3    Manning, B.D.4    Kwiatkowski, D.J.5
  • 66
    • 84896401739 scopus 로고    scopus 로고
    • Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway
    • Polivka J., Janku F. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol Ther 2014, 142(2):164-175.
    • (2014) Pharmacol Ther , vol.142 , Issue.2 , pp. 164-175
    • Polivka, J.1    Janku, F.2


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.